Nu Skin Enterprises Stock Forecast, Price & News

Nu Skin Enterprises' stock was trading at $21.06 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, NUS shares have increased by 149.3% and is now trading at $52.51.
View which stocks have been most impacted by COVID-19.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nu Skin Enterprises in the last year. There are currently 5 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Nu Skin Enterprises.

Nu Skin Enterprises is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Nu Skin Enterprises.

Nu Skin Enterprises will be holding an earnings conference call on Wednesday, November 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Nu Skin Enterprises, Inc. (NYSE:NUS) announced its quarterly earnings data on Wednesday, August, 5th. The company reported $0.81 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.67 by $0.14. The business had revenue of $612.37 million for the quarter, compared to analyst estimates of $606.02 million. Nu Skin Enterprises had a return on equity of 17.60% and a net margin of 6.33%.
View Nu Skin Enterprises' earnings history.

Nu Skin Enterprises announced a quarterly dividend on Wednesday, August 5th. Investors of record on Friday, August 28th will be paid a dividend of $0.375 per share on Wednesday, September 9th. This represents a $1.50 dividend on an annualized basis and a yield of 2.86%. The ex-dividend date is Thursday, August 27th.
View Nu Skin Enterprises' dividend history.

Nu Skin Enterprises issued an update on its third quarter 2020 After-Hours earnings guidance on Thursday, October, 1st. The company provided EPS guidance of for the period. The company issued revenue guidance of $700-703 million, compared to the consensus revenue estimate of $624.64 million.

8 analysts have issued twelve-month price targets for Nu Skin Enterprises' stock. Their forecasts range from $41.00 to $68.00. On average, they anticipate Nu Skin Enterprises' stock price to reach $55.57 in the next year. This suggests a possible upside of 5.8% from the stock's current price.
View analysts' price targets for Nu Skin Enterprises.

Nu Skin Enterprises saw a increase in short interest in September. As of September 15th, there was short interest totaling 1,520,000 shares, an increase of 11.8% from the August 31st total of 1,360,000 shares. Based on an average trading volume of 565,500 shares, the short-interest ratio is presently 2.7 days. Currently, 3.0% of the company's shares are short sold.
View Nu Skin Enterprises' Short Interest.

Some companies that are related to Nu Skin Enterprises include Estee Lauder Companies (EL), Herbalife Nutrition (HLF), USANA Health Sciences (USNA), Medifast (MED), Prestige Consumer Healthcare (PBH), Inter Parfums (IPAR), Revlon (REV), Nature's Sunshine Products (NATR) and Veru (VERU).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Nu Skin Enterprises investors own include Alibaba Group (BABA), General Electric (GE), NVIDIA (NVDA), Marathon Petroleum (MPC), Gilead Sciences (GILD), Alphabet (GOOG), Tesla (TSLA), Herbalife Nutrition (HLF), Mastercard (MA) and Netflix (NFLX).

Nu Skin Enterprises trades on the New York Stock Exchange (NYSE) under the ticker symbol "NUS."

Nu Skin Enterprises' stock is owned by a number of institutional and retail investors. Top institutional investors include Retirement Systems of Alabama (0.13%), Ingalls & Snyder LLC (0.10%), Pacer Advisors Inc. (0.04%), Louisiana State Employees Retirement System (0.02%), State of Alaska Department of Revenue (0.02%) and Alpha Windward LLC (0.02%). Company insiders that own Nu Skin Enterprises stock include D Matthew Dorny, Foulis Greg, Joseph Y Chang, Ritch N Wood and Ryan S Napierski.
View institutional ownership trends for Nu Skin Enterprises.

NUS stock was sold by a variety of institutional investors in the last quarter, including Ingalls & Snyder LLC, Alpha Windward LLC, Retirement Systems of Alabama, State of Alaska Department of Revenue, and Louisiana State Employees Retirement System. Company insiders that have sold Nu Skin Enterprises company stock in the last year include D Matthew Dorny, Joseph Y Chang, and Ryan S Napierski.
View insider buying and selling activity for Nu Skin Enterprises.

NUS stock was purchased by a variety of institutional investors in the last quarter, including Pacer Advisors Inc., V Wealth Advisors LLC, Paradigm Capital Management Inc. NY, Crossmark Global Holdings Inc., Cohen Klingenstein LLC, and Envestnet Asset Management Inc..
View insider buying and selling activity for Nu Skin Enterprises.

Shares of NUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of NUS stock can currently be purchased for approximately $52.51.

Nu Skin Enterprises has a market capitalization of $2.70 billion and generates $2.42 billion in revenue each year. The company earns $173.55 million in net income (profit) each year or $3.10 on an earnings per share basis. Nu Skin Enterprises employs 4,900 workers across the globe.

The official website for Nu Skin Enterprises is www.nuskinenterprises.com.

Nu Skin Enterprises' mailing address is 75 WEST CENTER ST, PROVO UT, 84601. The company can be reached via phone at 801-345-1000 or via email at [email protected]